UNICA IRIS Institutional Research Information System

COLUMBANO, AMEDEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 252.113
NA - Nord America 13.902
AS - Asia 5.007
SA - Sud America 712
Continente sconosciuto - Info sul continente non disponibili 375
AF - Africa 116
OC - Oceania 22
Totale 272.247
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 244.157
US - Stati Uniti d'America 13.618
NL - Olanda 4.812
SG - Singapore 1.909
CN - Cina 1.741
UA - Ucraina 888
SE - Svezia 648
BR - Brasile 530
DE - Germania 464
VN - Vietnam 434
FI - Finlandia 376
GB - Regno Unito 296
FR - Francia 249
HK - Hong Kong 167
CA - Canada 166
IN - India 120
BD - Bangladesh 115
KR - Corea 96
TR - Turchia 87
AR - Argentina 60
IQ - Iraq 47
JP - Giappone 47
RU - Federazione Russa 41
ID - Indonesia 38
MX - Messico 37
ZA - Sudafrica 33
CO - Colombia 28
PL - Polonia 28
PK - Pakistan 27
ES - Italia 26
BE - Belgio 24
VE - Venezuela 24
MA - Marocco 23
IR - Iran 22
AU - Australia 21
EC - Ecuador 21
SA - Arabia Saudita 21
JM - Giamaica 20
PH - Filippine 20
AT - Austria 18
CL - Cile 17
JO - Giordania 14
HN - Honduras 13
LT - Lituania 13
UZ - Uzbekistan 13
EG - Egitto 12
KE - Kenya 12
PY - Paraguay 12
IE - Irlanda 11
IL - Israele 11
MY - Malesia 11
PE - Perù 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
DZ - Algeria 9
CR - Costa Rica 8
BB - Barbados 6
BG - Bulgaria 6
KZ - Kazakistan 6
PR - Porto Rico 6
RO - Romania 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
EE - Estonia 5
ET - Etiopia 5
GT - Guatemala 5
MT - Malta 5
NI - Nicaragua 5
PS - Palestinian Territory 5
TH - Thailandia 5
UY - Uruguay 5
AL - Albania 4
BY - Bielorussia 4
CW - ???statistics.table.value.countryCode.CW??? 4
DO - Repubblica Dominicana 4
EU - Europa 4
GE - Georgia 4
HU - Ungheria 4
OM - Oman 4
PA - Panama 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
CI - Costa d'Avorio 3
DK - Danimarca 3
KH - Cambogia 3
NP - Nepal 3
PT - Portogallo 3
TW - Taiwan 3
BH - Bahrain 2
CY - Cipro 2
GP - Guadalupe 2
GR - Grecia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
MU - Mauritius 2
NO - Norvegia 2
RS - Serbia 2
SR - Suriname 2
Totale 271.856
Salva come PNG Salva come JPEG
Città #
Cagliari 239.805
Amsterdam 4.788
Uta 3.758
Ashburn 1.451
Fairfield 1.293
Singapore 975
San Jose 897
Woodbridge 854
Chandler 792
Houston 618
Boardman 564
Wilmington 531
Seattle 495
Ann Arbor 489
Nyköping 471
Jacksonville 464
Cambridge 441
Dallas 382
Beijing 346
Los Angeles 273
Dearborn 245
Helsinki 211
Santa Clara 202
Council Bluffs 175
Nanjing 153
Lauterbourg 152
Hong Kong 146
New York 142
Ho Chi Minh City 131
The Dalles 131
Boston 108
Buffalo 95
Hanoi 95
Hefei 92
Seoul 90
Shanghai 89
San Diego 80
Guangzhou 77
Toronto 72
São Paulo 68
Kocaeli 58
Shenyang 58
Nanchang 57
Redwood City 55
Changsha 52
Hebei 51
Milan 50
Falls Church 49
Chicago 48
San Mateo 48
Mountain View 45
London 43
Munich 40
Atlanta 38
Frankfurt am Main 38
Dong Ket 36
Jiaxing 36
Redondo Beach 36
Phoenix 34
Tianjin 33
Brooklyn 31
Orem 31
Tokyo 31
Jinan 28
Warsaw 27
Norwalk 26
Rome 26
Auburn Hills 24
Columbus 24
Montreal 24
Brussels 23
Leawood 22
Augusta 21
Orange 21
Verona 21
Baghdad 20
Nuremberg 20
Rio de Janeiro 20
Turku 20
Manchester 19
Stockholm 19
Chennai 18
Millbury 18
Zhengzhou 18
Da Nang 17
Denver 17
Johannesburg 17
Minneapolis 17
Detroit 16
Washington 16
Biên Hòa 15
Pune 15
Ardabil 14
Casablanca 14
Pisa 13
Amman 12
Dhaka 12
Haiphong 12
Hải Dương 12
Ningbo 12
Totale 263.929
Salva come PNG Salva come JPEG
Nome #
null 13.191
Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype 6.033
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3 4.986
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice 4.265
YAP activation is an early event and a potential therapeutic target in liver cancer development 4.087
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats 3.983
Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats 3.904
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells 3.784
Alpha-lipoic acid promotes the growth of rat hepatic preneoplastic lesions in the choline deficient model 3.751
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis 3.741
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.693
Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells 3.687
Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor 3.619
Emerging role of the pentose phosphate pathway in hepatocellular carcinoma 3.602
Clustered protocadherins methylation alterations in cancer 3.349
Induction of hepatocyte proliferation by retinoic acid 3.336
Sex difference in the proliferative response of mouse hepatocytes to treatment with the CAR ligand TCPOBOP 3.247
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 3.228
The peroxisome proliferator BR931 kills FaO cells by p53-dependent apotosis 3.205
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). 3.191
MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. 3.180
Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3) 3.141
Potential utility of xenobiotic mitogens in the context of liver regeneration in the elderly and living-related transplantation 3.140
Induction of autophagy promotes the growth of early preneoplastic rat liver nodules 3.114
The thyromimetic KB2115 (Eprotirome) induces rat hepatocyte proliferation 2.995
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 2.926
Regulatory effects of senescence marker protein 30 on the proliferation of hepatocytes 2.820
Reply to: "YAP in tumorigenesis: Friend or foe?" 2.777
A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis 2.760
Progenitor-derived hepatocellular carcinoma model in the rat 2.757
High frequency of β-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist 2.663
Timed regulation of P-element-induced wimpy testis-interacting RNA expression during rat liver regeneration 2.656
T3/TRs axis in hepatocellular carcinoma: new concepts for an old pair 2.644
Estimation of a significance threshold for epigenome-wide association studies 2.608
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression 2.562
Cell proliferation and cell death in rat liver carcinogenesis by chemicals 2.546
Thyroid hormone induces cyclin D1 nuclear translocation and DNA synthesis in adult rat cardiomyocytes 2.533
Effect of choline administration on the toxicity of N-nitrosodimethylamine in female rats 2.505
Induction of pancreatic acinar cell proliferation by thyroid hormone 2.495
The thyroid hormone receptor-beta agonist GC-1 induces cell proliferation in rat liver and pancreas 2.492
Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis 2.452
Ciprofibrate and triiodothyronine do not suppress in vivo induction of placental glutathione S-transferase expression in rat hepatocytes 2.401
null 2.399
Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene 2.394
Reply to: Clinical correlation of miR-375 and alpha-fetoprotein in hepatocellular carcinoma: comparison in mice and humans 2.371
Gadd 45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia 2.355
Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease 2.344
Gadd45β is an inducible coactivator of transcription that facilitates rapid liver growth in mice 2.243
Proteomic characterization of early changes induced by triiodothyronine in rat liver 2.187
Gender-specific interplay of signaling through β-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation 2.150
Cell proliferation induced by 3,3',5 triiodo L thyronine is associated with a reduction in the number of preneoplastic hepatic lesions 2.135
Triiodothyronine induces hepatocyte proliferation by protein kinase A-dependent-b-catenin activation in rodents. 2.120
DEXAMETHASONE INHIBITS INDUCTION OF LIVER-TUMOR NECROSIS FACTOR-ALPHA MESSENGER-RNA AND LIVER GROWTH INDUCED BY LEAD NITRATE AND ETHYLENE DIBROMIDE 2.103
Thyroid hormone receptor-β agonist induces β-catenin-dependent hepatocyte proliferation in mice: Implications in hepatic regeneration 1.973
AGING DOES NOT REDUCE THE HEPATOCYTE PROLIFERATIVE RESPONSE OF MICE TO THE PRIMARY MITOGEN TCPOBOP 1.949
METODO PER RILEVARE E/O PER LA PROGNOSI DI NEOPLASIE DEL COLON-RETTO 1.877
Different effects of regenerative and direct mitogenic stimuli on the growth of initiated cells in the resistant hepatocyte model 1.868
A large set of miRNAs is dysregulated from the earliest steps of human hepatocellular carcinoma development 1.858
Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis 1.827
miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling 1.806
Dexametasone inhibits induction of liver Tumor Necrosis Factor-a mRNA and liver growth induced by lead nitrate and ethylene dibromide 1.801
Different effects of the liver mitogens triiodo-thyronine and ciprofibrate on the development of rat hepatocellular carcinoma 1.801
Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas 1.794
The dual roles of NRF2 in cancer 1.738
Thyroid Hormone Receptor-β Agonist GC-1 Inhibits Met-β-Catenin-Driven Hepatocellular Cancer 1.737
Loss of cyclin D1 does not inhibit the proliferative response of mouse liver to mitogenic stimuli 1.719
Increased expression of c.fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOP 1.703
Animal models: A useful tool to unveil metabolic changes in hepatocellular carcinoma 1.690
Peroxisome proliferator-activated receptor-alpha(-/-) mice show enhanced hepatocyte proliferation in response to the hepatomitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene, a ligand of constitutive androstane receptor 1.662
Differences in the steady-state levels of c-fos, c-jun and c-myc messanger RNA during mitogen-induced liver growth and compensatory regeneration 1.660
Differential effects of choline administration on liver microsomes of female and male rats 1.659
Constitutive androstane receptor (Car)-driven regeneration protects liver from failure following tissue loss 1.640
Studies on the kinetics of expression of cell cycle dependent proto-oncogenes during mitogen-induced liver cell proliferation 1.599
MicroRNA: New Tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? 1.574
Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of trascription factors NF-kB and AP-1 or expression of tumor necrosis factor-alfa 1.510
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 1.479
Met as a therapeutic target in HCC: Facts and hopes 1.456
An electron microscopic study of apoptosis induced by cycloheximide in rat liver 1.437
A common set of immediate-early response genes in liver regeneration and hyperplasia 1.401
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 1.238
Early ultrastructural changes during thioacetamide-induced apoptosis in rat liver 1.200
Mitogenesis by ligands of nuclear receptors: an attractive model for the study of the molecular mechanisms implicated in liver growth 1.178
Genome-wide single nucleotide polymorphysm analysis of lung cancer risk detects the KLF6 gen 1.108
The TRbeta-selective agonist, GC-1, stimulates mitochondrial oxidative processes to a lesser extent than triiodothyronine 1.060
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration 991
Tg68, a novel thyroid hormone receptor‐β agonist for the treatment of NAFLD 987
Hexose monophosphate shunt and cholesterogenesis in lead-induced kidney hyperplasia 970
null 951
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 936
HMP-shunt and cholesterol metabolism in experimental models involving normal and preneoplastic liver growth. 902
Roles of growth factors and of tumor necrosis factor-alpha on liver cell proliferation induced in rats by lead nitrate 898
Stimulation of DNA synthesis after a single administration of cadmium nitrate. 891
Induction of 2 different modes of cell-death, apoptosis and necrosis, in rat-liver after a single dose of thioacetamide 888
Occurence of cell death (Apoptosis) during the involution of liver hyperplasia 877
Cell proliferation in rat kidney induced by 1,2-dibromoethane 876
T3 and the thyroid hormone beta-receptor agonist GC-1 differentially affect metabolic capacity and oxidative damage in rat tissues 875
Liver hyperplasia is not necessarily associated with increased expression of c-fos and c-myc mRNA 872
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis 864
Induction of cellular DNA synthesis in the pancreas and kidneys of rats by peroxisome proliferators, 9-cis retinoic acid, and 3,3',5-triiodo-L-thyronine 862
Cell deletion by apoptosis during regression of renal hyperplasia. 857
Totale 235.349
Salva come PNG Salva come JPEG
Categoria #
all - tutte 349.017
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 349.017
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210.120 0 0 0 919 1.129 1.048 748 561 1.468 1.236 1.423 1.588
2022/202319.224 1.491 2.529 2.506 1.704 1.674 1.833 994 1.502 1.175 1.324 1.568 924
2023/202419.982 1.380 925 1.896 1.415 1.808 2.537 2.702 1.442 910 1.379 1.788 1.800
2024/202530.988 7.855 8.128 3.496 3.015 1.668 2.020 2.223 180 336 1.351 299 417
2025/202613.831 598 577 937 898 816 586 2.240 519 4.410 1.281 596 373
2026/20272.262 341 393 657 871 0 0 0 0 0 0 0 0
Totale 272.247